Results 31 to 40 of about 97,726 (142)

Accuracy of New John Cunningham Virus Antibody Assay in Natalizumab-Treated Patients With Multiple Sclerosis.

open access: yesJAMA Neurology
This cross-sectional study examines the increase in positive results for John Cunningham virus antibodies and higher risk for progressive multifocal leukoencephalopathy among patients with multiple sclerosis receiving natalizumab.
Liza M Y Gelissen   +9 more
semanticscholar   +3 more sources

Molecular Interplay of John Cunningham Virus with Interleukin 1 Beta in Colorectal Carcinomatous Tissues from a Group of Iraqi Patients. [PDF]

open access: yesArch Razi Inst, 2022
Muhsen M Ali Z   +5 more
europepmc   +2 more sources

Mapping the history and current situation of research on John Cunningham virus - a bibliometric analysis. [PDF]

open access: yesBMC Infect Dis, 2009
John Cunningham virus (JCV) constitutes a family of polyoma viruses, which plays important roles in the progressive multifocal leukoencephalopathy (PML) and tumorigenesis. However, no bibliometric investigation has been reported to guide the researchers and potential readers.Papers were collected from database Sci-expanded and Pubmed until May 22, 2008.
Zheng HC   +4 more
europepmc   +5 more sources

Progressive multifocal leukoencephalopathy in a lung transplant recipient: Isolation of John Cunningham (JC) virus from bronchoalveolar lavage

open access: yesJournal of Global Infectious Diseases, 2016
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system caused by polyomavirus John Cunningham (JC) virus.
Tanmay S Panchabhai   +4 more
doaj   +3 more sources

Serum anti-John Cunningham virus antibody seroprevalence and index among Japanese patients with neuromyelitis optica spectrum disorders [PDF]

open access: yesMultiple Sclerosis Journal, 2018
Anti-John Cunningham virus antibody (JCVAb) is a progressive multifocal leucoencephalopathy (PML) risk indicator in patients with multiple sclerosis (MS) receiving natalizumab treatment.
S. Aoyama   +6 more
semanticscholar   +3 more sources

A Chronic Lymphocytic Leukemia Patient with Progressive Multifocal Leukoencephalopathy Caused by John Cunningham Virus

open access: yesActa Medica Indonesiana, 2018
Progressive multifocal leukoencephalopathy (PML) is a rare but fatal disease leading to severe neurological impairments. PML is a clinical manifestation, which is usually associated with John Cunningham virus (JCV) infection.
Pristya Ramadhani   +2 more
doaj   +5 more sources

Progressive multifocal leukoencephalopathy caused by the John Cunningham virus: a case report

open access: yesRevista de la Facultad de Medicina
Introduction: Progressive multifocal leukoencephalopathy (PML) is a demyelinating, multifactorial disease that can be caused by the John Cunningham virus (JCV) and occurs mainly in people with HIV/AIDS.
Dario Fernando Muñoz-Mora   +2 more
doaj   +2 more sources

Beyond Uremia: Chronic Kidney Disease as a Cryptic Gateway for Opportunistic Neuroinvasion by John Cunningham Virus

open access: yesAnnals of Internal Medicine: Clinical Cases
Progressive multifocal leukoencephalopathy (PML), a devastating demyelinating central nervous system infection caused by John Cunningham virus (JCV) reactivation, typically occurs in profound immunosuppression.
Ethar Salman, Kalyan K. Shastri
doaj   +2 more sources

Genotypes of John Cunningham (JC) Virus Urinary Excretion in Pregnant and Non-Pregnant Women in Isfahan, Iran

open access: yesJournal of Family and Reproductive Health, 2018
Objective: To evaluate presence of different subtypes and genetic variations of JC virus in different geographical areas is a useful tool for reconstructing of the genetic information and understanding of the evolution of the virus and also in tracing of
Sayyedeh Rahmaneh Atyabi   +2 more
doaj   +2 more sources

Progressive multifocal leukoencephalopathy successfully treated with mefloquine and literature review [PDF]

open access: yesEncephalitis, 2021
Progressive multifocal leukoencephalopathy (PML) is an opportunistic infection due to reactivation of John Cunningham virus (JCV). The diagnosis depends on evidence from clinical, imaging, and virologic studies.
Sungjoon Yoon   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy